Dietary whey hydrolysate with exercise alters the plasma protein profile: A comprehensive protein analysis

Nutrition

Volumn 27, Issue 6, 2011, Pages 687-692

  Aoi, Wataru ^a   Takanami, Yoshikazu ^b   Kawai, Yukari ^c   Morifuji, Masashi ^d   Koga, Jinichiro ^d   Kanegae, Minoru ^d   Mihara, Kenichi ^e   Yanohara, Taishi ^e   Mukai, Jun ^e   Naito, Yuji ^f   Yoshikawa, Toshikazu ^f  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

^b OTSUMA WOMEN'S UNIVERSITY   (Japan)

^c Louis Pasteur Center for Medical Research   (Japan)

^d MEIJI SEIKA KAISHA LTD   (Japan)

^e Biomarker Science Co Ltd   (Japan)

^f KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Exercise performance; Mice; Muscle glycogen; Proteomics

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN C1; BETA2 GLYCOPROTEIN 1; GLYCOGEN; PROTEIN HYDROLYSATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; ENDURANCE TRAINING; GASTROCNEMIUS MUSCLE; GLYCOGEN MUSCLE LEVEL; GLYCOGEN SYNTHESIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; WHEY;

ANIMALS; APOLIPOPROTEINS; APOLIPOPROTEINS A; APOLIPOPROTEINS C; BETA 2-GLYCOPROTEIN I; BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; GLYCOGEN; MALE; MICE; MICE, INBRED C57BL; MILK PROTEINS; MOTOR ACTIVITY; MUSCLE, SKELETAL; PERFORMANCE-ENHANCING SUBSTANCES; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL ENDURANCE; PROTEIN ARRAY ANALYSIS; PROTEIN HYDROLYSATES; PROTEIN ISOFORMS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

MUS;

EID: 79955599910     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2010.06.004     Document Type: Article

References (32)

1. de Wit J.N. Nutritional and functional characteristics of whey proteins in food products. J Dairy Sci 1998, 81:597-608.
2. Hayes A., Cribb P.J. Effect of whey protein isolate on strength, body composition and muscle hypertrophy during resistance training. Curr Opin Clin Nutr Metab Care 2008, 11:40-44.
3. Dangin M., Guillet C., Garcia-Rodenas C., Gachon P., Bouteloup-Demange C., Reiffers-Magnani K., et al. The rate of protein digestion affects protein gain differently during aging in humans. J Physiol 2003, 549:635-644.
4. Hall W.L., Millward D.J., Long S.J., Morgan L.M. Casein and whey exert different effects on plasma amino acid profiles, gastrointestinal hormone secretion and appetite. Br J Nutr 2003, 89:239-248.
5. Betts J.A., Williams C., Boobis L., Tsintzas K. Increased carbohydrate oxidation after ingesting carbohydrate with added protein. Med Sci Sports Exerc 2008, 40:903-912.
6. Morifuji M., Sakai K., Sanbongi C., Sugiura K. Dietary whey protein increases liver and skeletal muscle glycogen levels in exercise-trained rats. Br J Nutr 2005, 93:439-445.
7. Morifuji M., Sakai K., Sugiura K. Dietary whey protein modulates liver glycogen level and glycoregulatory enzyme activities in exercise-trained rats. Exp Biol Med 2005, 230:23-30.
8. Saito S., Yoshitake Y., Suzuki M. Enhanced glycogen repletion in liver and skeletal muscle with citrate orally fed after exhaustive treadmill running and swimming. J Nutr Sci Vitaminol 1983, 29:45-52.
9. Ivy J.L., Goforth H.W., Damon B.M., McCauley T.R., Parsons E.C., Price T.B. Early postexercise muscle glycogen recovery is enhanced with a carbohydrate-protein supplement. J Appl Physiol 2002, 93:1337-1344.
10. van Hall G., Saris W.H., van de Schoor P.A., Wagenmakers A.J. The effect of free glutamine and peptide ingestion on the rate of muscle glycogen resynthesis in man. Int J Sports Med 2000, 21:25-30.
11. Zhang Z., Bast R.C., Yu Y., Li J., Sokoll L.J., Rai A.J., et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004, 64:5882-5890.
12. Engwegen J.Y., Mehra N., Haanen J.B., Bonfrer J.M., Schellens J.H., Voest E.E., et al. Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations. Lab Invest 2007, 87:161-172.
13. Kim H.J., Cho E.H., Yoo J.H., Kim P.K., Shin J.S., Kim M.R., et al. Proteome analysis of serum from type 2 diabetics with nephropathy. J Proteome Res 2007, 6:735-743.
14. Merchant M.L., Klein J.B. Proteomics and diabetic nephropathy. Semin Nephrol 2007, 27:627-636.
15. Dursun E., Ozben B., Monari E., Cuoghi A., Tomasi A., Ozben T. Proteomic profiling in apolipoprotein E-deficient mice during atherosclerosis progression. Acta Histochem 2010, 112:178-188.
16. Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol 2005, 563:23-60.
17. Billat V.L., Mouisel E., Roblot N., Melki J. Inter- and intrastrain variation in mouse critical running speed. J Appl Physiol 2005, 98:1258-1263.
18. Kemi O.J., Loennechen J.P., Wisløff U., Ellingsen Ø Intensity-controlled treadmill running in mice: cardiac and skeletal muscle hypertrophy. J Appl Physiol 2002, 93:1301-1309.
19. Passonneau J.V., Lauderdale V.R. A comparison of three methods of glycogen measurement in tissues. Anal Biochem 1974, 60:405-412.
20. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
21. Morifuji M., Koga J., Kawanaka K., Higuchi M. Branched-chain amino acid-containing dipeptides, identified from whey protein hydrolysates, stimulate glucose uptake rate in L6 myotubes and isolated skeletal muscles. J Nutr Sci Vitaminol 2009, 55:81-86.
22. Kussmann M., Affolter M. Proteomics at the center of nutrigenomics: comprehensive molecular understanding of dietary health effects. Nutrition 2009, 25:1085-1093.
23. Blanco-Vaca F., Escolà-Gil J.C., Martín-Campos J.M., Julve J. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J Lipid Res 2001, 42:1727-1739.
24. Tailleux A., Duriez P., Fruchart J.C., Clavey V. Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis 2002, 164:1-13.
25. Durbin D.M., Jonas A. The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle. J Biol Chem 1997, 272:31333-31339.
26. Boucher J., Ramsamy T.A., Braschi S., Sahoo D., Neville T.A., Sparks D.L. Apolipoprotein A-II regulates HDL stability and affects hepatic lipase association and activity. J Lipid Res 2004, 45:849-858.
27. Julve J., Escolà-Gil J.C., Rotllan N., Fiévet C., Vallez E., de la Torre C., et al. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome. Arterioscler Thromb Vasc Biol 2010, 30:232-238.
28. Jong M.C., Hofker M.H., Havekes L.M. Role of apoCs in lipoprotein metabolism. Functional differences between apoC1, apoC2, and apoC3. Arterioscler Thromb Vasc Biol 1999, 19:472-484.
29. Huang S., Qiao J., Li R., Wang L., Li M. Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome?. Fertil Steril 2010, 94:205-210.
30. Yu P., Passam F.H., Yu D.M., Denyer G., Krilis S.A. Beta2-glycoprotein I inhibits vascular endothelial growth factor and basic fibroblast growth factor induced angiogenesis through its amino terminal domain. J Thromb Haemost 2008, 6:1215-1223.
31. Sakai T., Balasubramanian K., Maiti S., Halder J.B., Schroit A.J. Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis. Am J Pathol 2007, 171:1659-1669.
32. Boirie Y., Dangin M., Gachon P., Vasson M.P., Maubois J.L., Beaufrère B. Slow and fast dietary proteins differently modulate postprandial protein accretion. Proc Natl Acad Sci U S A 1997, 94:14930-14935.